Volume changes after segmental vapor ablation and associated improvements in FEV1
Arschang Valipour (Wien, Austria), Arschang Valipour, Daniela Gompelmann, Pallav Shah, Christian Grah, Jim Egan, Joachim Ficker, Manfred Wagner, Christian Witt, Uta Liebers, Peter Hopkins, Wolfgang Gesierich, Martin Phillips, Franz Stanzel, William Mcnulty, Christoph Petermann, Greg Snell, Daniel Chambers, Felix Herth
Source: International Congress 2016 – Endoscopic lung volume reduction II
Session: Endoscopic lung volume reduction II
Session type: Poster Discussion
Number: 1851
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Arschang Valipour (Wien, Austria), Arschang Valipour, Daniela Gompelmann, Pallav Shah, Christian Grah, Jim Egan, Joachim Ficker, Manfred Wagner, Christian Witt, Uta Liebers, Peter Hopkins, Wolfgang Gesierich, Martin Phillips, Franz Stanzel, William Mcnulty, Christoph Petermann, Greg Snell, Daniel Chambers, Felix Herth. Volume changes after segmental vapor ablation and associated improvements in FEV1. Eur Respir J 2016; 48: Suppl. 60, 1851
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Targeted segmental volume reduction with vapor ablation in emphysema results in reduced RV and clinically meaningful improvement (CMI) in FEV1 Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016
Targeted vapor ablation as a new method for endoscopic lung volume reduction at segmental level Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016
Dynamic hyperinflation after bronchial lung volume reduction: An expected effect or perhaps a preoperative test for selection? Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013
Lung volume reduction coil treatment restores lung compliance in patients with homogeneous emphysema Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013
Endoscopic lung volume reduction (ELVR) in COPD: Improvements in gas transfer capacity correlate with improvements in ventilation and perfusion (VQ) matching Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015
Flow-volume parameters in COPD related to extended measurements of lung volume, diffusion and resistance Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013
Segmental lung volume reduction (LVR) with vapor better targets disease heterogeneity as compared to lobar LVR Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016
Endoscopic lung volume reduction in low FEV1 patients Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016
Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013
Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema Source: Eur Respir J 2012; 39: 1326-1333 Year: 2012
Echocardiogram parameters in patients with COPD in the year after endoscopic lung volume reduction (ELVR) Source: International Congress 2015 – Bronchoscopic treatment of emphysema and asthma: what is new? Year: 2015
Bronchoscopic lung volume reduction with endobronchial valves improves exercise capacity but not oxygen uptake kinetics in a group of patients with severe emphysema Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases Year: 2013
Endoscopic lung volume reduction with nitinol coils in very severe emphysema: Mid-term effectiveness vs. disease related continuous loss of lung function Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015
FEV6 as an alternative for FVC in detecting airflow obstruction in COPD patients undergoing six minute Walk test Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity Year: 2013
The ratio of inspiratory ΣRrs to expiratory ΣRrs measured by forced oscillation technique correlates with the parameters reflecting narrowing of small airway measured by spirometry in patients with mild to moderate COPD Source: Annual Congress 2013 –New issues in lung function testing Year: 2013
Endoscopic lung volume reduction (ELVR) in COPD: Changes in lung mechanics with ELVR using the forced oscillation technique (FOT) Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016
Measurement of lung function deterioration in COPD by V/P SPECT Source: International Congress 2016 – Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception Year: 2016
COPD severity related to extended measurements of lung volume, diffusion, and resistance Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014
Unilateral treatment with lung volume reduction coils in patients with severe emphysema Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013
The long-term functional changes in COPD patients effected to the ionization radiation Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015